| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 425 | 1.082 | 1.273 | 4.220 | 948 | 12.005 | 742 | 659 |
| Total Income - EUR | - | - | 3.245 | 3.059 | 1.846 | 4.220 | 9.904 | 12.005 | 11.176 | 5.452 |
| Total Expenses - EUR | - | - | 2.959 | 2.759 | 1.584 | 3.562 | 9.001 | 11.152 | 10.328 | 4.598 |
| Gross Profit/Loss - EUR | - | - | 287 | 301 | 261 | 658 | 903 | 853 | 849 | 854 |
| Net Profit/Loss - EUR | - | - | 189 | 209 | 206 | 532 | 646 | 751 | 754 | 808 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Berryland Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 739 | 12.814 | 8.948 | 5.419 | 2.314 |
| Current Assets | - | - | 671 | 691 | 2.281 | 3.172 | 6.437 | 6.924 | 8.284 | 8.509 |
| Inventories | - | - | 339 | 0 | 0 | 0 | 0 | 0 | 0 | 165 |
| Receivables | - | - | 185 | 515 | 2.183 | 3.085 | 6.370 | 6.717 | 7.227 | 7.815 |
| Cash | - | - | 148 | 176 | 97 | 86 | 67 | 206 | 1.057 | 528 |
| Shareholders Funds | - | - | 233 | 481 | 678 | 1.196 | 1.816 | 2.573 | 3.319 | 4.108 |
| Social Capital | - | - | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 438 | 210 | 1.603 | 2.714 | 17.435 | 13.299 | 10.384 | 6.715 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Berryland Bio Srl